Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer

NCT00073528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1286

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Lapatinib
DRUG: Letrozole
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals